Status:
NOT_YET_RECRUITING
Risk Factor Analysis for Charcot Foot in Patients With Diabetes Mellitus: The Interplay of Inflammatory Cytokines and Metabolic Factors
Lead Sponsor:
Assiut University
Conditions:
Charcot Foot
Eligibility:
All Genders
Brief Summary
Diabetes mellitus (DM) is among the most common metabolic disorders globally. According to the data from international research, the number of persons with diabetes mellitus reached 366 million in 201...
Detailed Description
Hyperglycaemia is a hallmark of diabetes mellitus resulting from defects in insulin secretion, insulin action, or both. Diabetes-related chronic hyperglycaemia is linked to long-term harm complication...
Eligibility Criteria
Inclusion
- Inclusion . Inclusion criteria:
- Adult Patients who are diagnosed with DM who are willing to participate in the study with informed consent form.
- b. Exclusion criteria:
- Patients with neuritis / neuropathy of the lower extremity due to other causes other than DM
- Significant trauma that may cause peripheral nerve damage.
- Patient with routine use of corticosteroid
- Previous history of smoking
- Patients with chronic renal impairment due to diseases other than DM (creatinine \> 1.4 mg/dL), previous myocardial infarction or stroke, history of cancer.
- Patients with iron deficiency anemia or uremia affecting HbA1c levels or elevated triglyceride or bilirubin levels.
- Patients diagnosed with neurological disease, malignancy.
Exclusion
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07139184
Start Date
October 1 2025
End Date
October 1 2027
Last Update
August 24 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.